These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10922382)

  • 1. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.
    Borrego S; Ruiz A; Saez ME; Gimm O; Gao X; López-Alonso M; Hernández A; Wright FA; Antiñolo G; Eng C
    J Med Genet; 2000 Aug; 37(8):572-8. PubMed ID: 10922382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression.
    Borrego S; Sáez ME; Ruiz A; Gimm O; López-Alonso M; Antiñolo G; Eng C
    J Med Genet; 1999 Oct; 36(10):771-4. PubMed ID: 10528857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.
    Borrego S; Wright FA; Fernández RM; Williams N; López-Alonso M; Davuluri R; Antiñolo G; Eng C
    Am J Hum Genet; 2003 Jan; 72(1):88-100. PubMed ID: 12474140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR).
    Fitze G; Appelt H; König IR; Görgens H; Stein U; Walther W; Gossen M; Schreiber M; Ziegler A; Roesner D; Schackert HK
    Hum Mol Genet; 2003 Dec; 12(24):3207-14. PubMed ID: 14600022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.
    Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A
    Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Within-gene interaction between c.135 G/A genotypes and RET proto-oncogene germline mutations in HSCR families.
    Fitze G; Cramer J; Serra A; Schreiber M; Roesner D; Schackert HK
    Eur J Pediatr Surg; 2003 Jun; 13(3):152-7. PubMed ID: 12939698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
    Lesueur F; Corbex M; McKay JD; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar DE; Romeo G
    J Med Genet; 2002 Apr; 39(4):260-5. PubMed ID: 11950855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ancestral RET haplotype associated with Hirschsprung's disease shows linkage disequilibrium breakpoint at -1249.
    Fernandez RM; Boru G; Peciña A; Jones K; López-Alonso M; Antiñolo G; Borrego S; Eng C
    J Med Genet; 2005 Apr; 42(4):322-7. PubMed ID: 15805159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR; Boru G; Binkley PK; Peczkowska M; Januszewicz AA; Neumann HP; Eng C
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4911-6. PubMed ID: 14557473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
    Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A
    Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.
    Burzynski GM; Nolte IM; Osinga J; Ceccherini I; Twigt B; Maas S; Brooks A; Verheij J; Plaza Menacho I; Buys CH; Hofstra RM
    Eur J Hum Genet; 2004 Aug; 12(8):604-12. PubMed ID: 15138456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare haplotype of the RET proto-oncogene is a risk-modifying allele in hirschsprung disease.
    Griseri P; Pesce B; Patrone G; Osinga J; Puppo F; Sancandi M; Hofstra R; Romeo G; Ravazzolo R; Devoto M; Ceccherini I
    Am J Hum Genet; 2002 Oct; 71(4):969-74. PubMed ID: 12214285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel intronic polymorphisms in the RET proto-oncogene and their association with Hirschsprung disease.
    Fitze G; Schierz M; Kuhlisch E; Schreiber M; Ziegler A; Roesner D; Schackert HK
    Hum Mutat; 2003 Aug; 22(2):177. PubMed ID: 12872262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.
    Edery P; Pelet A; Mulligan LM; Abel L; Attié T; Dow E; Bonneau D; David A; Flintoff W; Jan D
    J Med Genet; 1994 Aug; 31(8):602-6. PubMed ID: 7815416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET 3'UTR polymorphisms and its protective role in Hirschsprung disease in southeastern Chinese.
    Pan ZW; Luo CF; Liu ZJ; Li JC
    J Pediatr Surg; 2012 Sep; 47(9):1699-705. PubMed ID: 22974609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of RET mutations in patients with Hirschsprung's disease.
    Sancandi M; Ceccherini I; Costa M; Fava M; Chen B; Wu Y; Hofstra R; Laurie T; Griffths M; Burge D; Tam PK
    J Pediatr Surg; 2000 Jan; 35(1):139-42; discussion 142-3. PubMed ID: 10646792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
    Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S
    Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.
    Gath R; Goessling A; Keller KM; Koletzko S; Coerdt W; Müntefering H; Wirth S; Hofstra RM; Mulligan L; Eng C; von Deimling A
    Gut; 2001 May; 48(5):671-5. PubMed ID: 11302967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
    Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
    Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease.
    Vaclavikova E; Dvorakova S; Skaba R; Pos L; Sykorova V; Halkova T; Vcelak J; Bendlova B
    PLoS One; 2014; 9(6):e98957. PubMed ID: 24897126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.